Patent details
990012
Product Name:
Salmeterol, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout, en Fluticasonpropionaat,in het bijzonder Salmeterolxinafoaat en Fluticasonpropionaat.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
990012
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP0416951
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
990012
Procedural language:
Dutch
First Applicant Residence Country:
Marketing Authorization
1
Marketing Authorization Number:
14591
Marketing Authorization Type:
EEA
Marketing Authorization Date:
07/09/1998
Marketing Authorization Country:
Sweden (SE)
2
Marketing Authorization Number:
14592
Marketing Authorization Type:
EEA
Marketing Authorization Date:
07/09/1998
Marketing Authorization Country:
Sweden (SE)
3
Marketing Authorization Number:
14593
Marketing Authorization Type:
EEA
Marketing Authorization Date:
07/09/1998
Marketing Authorization Country:
Sweden (SE)
4
Marketing Authorization Number:
14594
Marketing Authorization Type:
EEA
Marketing Authorization Date:
07/09/1998
Marketing Authorization Country:
Sweden (SE)
5
Marketing Authorization Number:
14595
Marketing Authorization Type:
EEA
Marketing Authorization Date:
07/09/1998
Marketing Authorization Country:
Sweden (SE)
6
Marketing Authorization Number:
14596
Marketing Authorization Type:
EEA
Marketing Authorization Date:
07/09/1998
Marketing Authorization Country:
Sweden (SE)
7
Marketing Authorization Number:
RVG 23529
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/01/1999
Marketing Authorization Country:
Netherlands (NL)
8
Marketing Authorization Number:
RVG 23530
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/01/1999
Marketing Authorization Country:
Netherlands (NL)
9
Marketing Authorization Number:
RVG 23531
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/01/1999
Marketing Authorization Country:
Netherlands (NL)
10
Marketing Authorization Number:
RVG 23532
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/01/1999
Marketing Authorization Country:
Netherlands (NL)
11
Marketing Authorization Number:
RVG 23533
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/01/1999
Marketing Authorization Country:
Netherlands (NL)
12
Marketing Authorization Number:
RVG 23534
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/01/1999
Marketing Authorization Country:
Netherlands (NL)
Dates
Filing date:
14/04/1999
First Marketing Authorization date:
07/09/1998
Grant date:
09/06/1999
Activation date:
07/09/2010
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
14/04/1999
SPC/SPC Extension Expiration Date:
06/09/2013
Lapsed By Expiration Date:
07/09/2013
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
14/04/1999
Name:
GLAXO GROUP LIMITED
Address:
Glaxo Wellcome House Berkeley Avenue, UB6 0NN, Greenford, Middlesex, United Kingdom (GB)
Agent
Name:
ir. F.A. Geurts c.s.
From:
14/04/1999
Address:
Octrooibureau Vriesendorp & Gaade B.V.
Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
2013/38
Publication date:
18/09/2013
Description:
Lapse or annulment
2
Bulletin Heading:
SPC
Journal edition number:
1999/08
Publication date:
02/08/1999
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
Bulletin Heading:
SPC
Journal edition number:
1999/07
Publication date:
01/07/1999
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Registration Summons/Subpoena
Change Kind/ Decision Type:
For Invalidity declaration
Deed Number:
54688-A054688-1
Date Registered:
07/12/2009
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Brinkhof
Journal Edition Number:
Text:
Indiening dagvaarding nietigverklaring 7 december 2009 door Brinkhof advocaten te Amsterdam. Verzoekers zijn Sandoz BV te Amere en Hexal AG te Holzkirchen. Gedaagde partij is Glaxo Group Limited te Londen. Zie verder de akte 54688.
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Annual Fee
Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
13/07/2012
Last Annual Fee Paid Number:
23
Last Annual Fee Paid Amount:
2000 Euro
Payer:
Thomson IP Management Services (Master Data)
Filing date
Document type
Document Description
Number of pages
File Type
09/06/1999
Outgoing Correspondence
Outgoing Letter
1
PDF
/2/1/0/0/9/0400990012/docs/990012_2_outgoingcorrespondence19990609.pdf
09/06/1999
Outgoing Correspondence
Outgoing Letter
1
PDF
/2/1/0/0/9/0400990012/docs/990012_3_outgoingcorrespondence19990609.pdf
14/04/1999
General
3
PDF
/2/1/0/0/9/0400990012/docs/990012_0_spc-documents19990414.pdf
14/04/1999
General
3
PDF
/2/1/0/0/9/0400990012/docs/990012_1_spc-documents19990414.pdf
14/04/1999
General
3
PDF
/2/1/0/0/9/0400990012/docs/990012_4_spc-documents19990414.pdf
14/04/1999
General
7
PDF
/2/1/0/0/9/0400990012/docs/990012_5_spc-documents19990414.pdf
14/04/1999
Application Form
First filed application form
2
PDF
/2/1/0/0/9/0400990012/docs/990012_6_applicationform19990414.pdf
14/04/1999
General
7
PDF
/2/1/0/0/9/0400990012/docs/990012_7_spc-documents19990414.pdf
14/04/1999
General
2
PDF
/2/1/0/0/9/0400990012/docs/990012_8_spc-documents19990414.pdf